Your browser doesn't support javascript.
loading
Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy.
Jeon, Yun-Hui; Lee, Namhee; Yoo, Jiyoon; Won, Solchan; Shin, Suk-Kyung; Kim, Kyu-Hwan; Park, Jun-Gyu; Kim, Min-Gang; Kim, Hang-Rae; Oh, Keunhee; Lee, Dong-Sup.
Afiliação
  • Jeon YH; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee N; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.
  • Yoo J; SillaJen, Inc. Research Center, Seongnam-si 13493, Korea.
  • Won S; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Shin SK; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.
  • Kim KH; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Park JG; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.
  • Kim MG; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Kim HR; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.
  • Oh K; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee DS; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.
Biomedicines ; 10(4)2022 Mar 30.
Article em En | MEDLINE | ID: mdl-35453555

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article